Silencing of MED27 inhibits adrenal cortical carcinogenesis by targeting the Wnt/β-catenin signaling pathway and the epithelial-mesenchymal transition process

References

Arend, R.C., Londono-Joshi, A.I., Gangrade, A., Katre, A.A., Kurpad, C., Li, Y., Samant, R.S., Li, P.-K., Landen, C.N., Yang, E.S., et al. (2016). Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer. Oncotarget 7, 86803–86815.10.18632/oncotarget.13466Search in Google Scholar PubMed PubMed Central

Barasch, J. (2001). Genes and proteins involved in mesenchymal to epithelial transition. Curr. Opin. Nephrol. Hypertens. 10, 429–436.10.1097/00041552-200105000-00021Search in Google Scholar PubMed

Berthon, A., Sahut-Barnola, I., Lambert-Langlais, S., de Joussineau, C., Damon-Soubeyrand, C., Louiset, E., Taketo, M.M., Tissier, F., Bertherat, J., Lefrançois-Martinez, A.M., et al. (2010). Constitutive beta-catenin activation induces adrenal hyperplasia and promotes adrenal cancer development. Hum. Mol. Genet. 19, 1561–1576.10.1093/hmg/ddq029Search in Google Scholar PubMed

Bourbon, H.M. (2008). Comparative genomics supports a deep evolutionary origin for the large, four-module transcriptional mediator complex. Nucleic Acids Res. 36, 3993–4008.10.1093/nar/gkn349Search in Google Scholar PubMed PubMed Central

Cani, A.K., Hovelson, D.H., McDaniel, A.S., Sadis, S., Haller, M.J., Yadati, V., Amin, A.M., Bratley, J., Bandla, S., Williams, P.D., et al. (2015). Next-generation sequencing exposes frequent MED12 mutations and actionable therapeutic targets in phyllodes tumors. Mol. Cancer Res. 13, 613–619.10.1158/1541-7786.MCR-14-0578Search in Google Scholar PubMed PubMed Central

Fassnacht, M., Kroiss, M., and Allolio, B. (2013). Update in adrenocortical carcinoma. J. Clin. Endocrinol. Metab. 98, 4551–4564.10.1210/jc.2013-3020Search in Google Scholar PubMed

Ghahhari, N.M. and Babashah, S. (2015). Interplay between microRNAs and WNT/β-catenin signalling pathway regulates epithelial-mesenchymal transition in cancer. Eur. J. Cancer 51, 1638–1649.10.1016/j.ejca.2015.04.021Search in Google Scholar PubMed

Huang, S., Holzel, M., Knijnenburg, T., Schlicker, A., Roepman, P., McDermott, U., Garnett, M., Grernrum, W., Sun, C., Prahallad, A., et al. (2012). MED12 controls the response to multiple cancer drugs through regulation of TGF-β receptor signaling. Cell 151, 937–950.10.1016/j.cell.2012.10.035Search in Google Scholar PubMed PubMed Central

Kim, A.C., Reuter, A.L., Zubair, M., Else, T., Serecky, K., Bingham, N.C., Lavery, G.G., Parker, K.L., and Hammer, G.D. (2008). Targeted disruption of beta-catenin in Sf1-expressing cells impairs development and maintenance of the adrenal cortex. Development 135, 2593–2602.10.1242/dev.021493Search in Google Scholar PubMed

Klumper, N., Syring, I., Vogel, W., Schmidt, D., Muller, S.C., Ellinger, J., Shaikhibrahim, Z., Brägelmann, J., and Perner, S. (2017). Mediator complex subunit MED1 Protein expression is decreased during bladder cancer progression. Front Med. (Lausanne) 4, 30.10.3389/fmed.2017.00030Search in Google Scholar PubMed PubMed Central

Liu-Chittenden, Y., Jain, M., Gaskins, K., Wang, S., Merino, M.J., Kotian, S., Kumar Gara, S., Davis, S., Zhang, L., and Kebebew, E. (2017). RARRES2 functions as a tumor suppressor by promoting β-catenin phosphorylation/degradation and inhibiting p38 phosphorylation in adrenocortical carcinoma. Oncogene 36, 3541–3552.10.1038/onc.2016.497Search in Google Scholar PubMed PubMed Central

Nagalingam, A., Tighiouart, M., Ryden, L., Joseph, L., Landberg, G., Saxena, N.K., and Sharma, D. (2012). Med1 plays a critical role in the development of tamoxifen resistance. Carcinogenesis 33, 918–930.10.1093/carcin/bgs105Search in Google Scholar PubMed PubMed Central

Ruiz, A., Pauls, E., Badia, R., Riveira-Munoz, E., Clotet, B., Ballana, E., and Esté, J.A. (2014). Characterization of the influence of mediator complex in HIV-1 transcription. J. Biol. Chem. 289, 27665–27676.10.1074/jbc.M114.570341Search in Google Scholar PubMed PubMed Central

Ryu, S., Zhou, S., Ladurner, A.G., and Tjian, R. (1999). The transcriptional cofactor complex CRSP is required for activity of the enhancer-binding protein Sp1. Nature 397, 446.10.1038/17141Search in Google Scholar PubMed

Saito, R.A., Watabe, T., Horiguchi, K., Kohyama, T., Saitoh, M., Nagase, T., and Miyazono, K. (2009). Thyroid transcription factor-1 inhibits transforming growth factor-β-mediated epithelial-to-mesenchymal transition in lung adenocarcinoma cells. Cancer Res. 69, 2783–2791.10.1158/0008-5472.CAN-08-3490Search in Google Scholar PubMed

Salomon, A., Keramidas, M., Maisin, C., and Thomas, M. (2015). Loss of β-catenin in adrenocortical cancer cells causes growth inhibition and reversal of epithelial-to-mesenchymal transition. Oncotarget 6, 11421–11433.10.18632/oncotarget.3222Search in Google Scholar PubMed PubMed Central

Shaikhibrahim, Z., Menon, R., Braun, M., Offermann, A., Queisser, A., Boehm, D., Vogel, W., Rüenauver, K., Ruiz, C., Zellweger, T., et al. (2014). MED15, encoding a subunit of the mediator complex, is overexpressed at high frequency in castration-resistant prostate cancer. Int. J. Cancer 135, 19–26.10.1002/ijc.28647Search in Google Scholar PubMed

Tang, R., Xu, X., Yang, W., Yu, W., Hou, S., Xuan, Y., Tang, Z., Zhao, S., Chen, Y., Xiao, X., et al. (2016). MED27 promotes melanoma growth by targeting AKT/MAPK and NF-κB/iNOS signaling pathways. Cancer Lett. 373, 77–87.10.1016/j.canlet.2016.01.005Search in Google Scholar PubMed

Varghese, J. and Habra, M.A. (2017). Update on adrenocortical carcinoma management and future directions. Curr. Opin. Endocrinol. Diabet Obes. 24, 208–214.10.1097/MED.0000000000000332Search in Google Scholar PubMed

Xu, Y., Dong, B., Huang, J., Kong, W., Xue, W., Zhu, Y., Zhang, J., and Huang, Y. (2016). Sphingosine kinase 1 is overexpressed and promotes adrenocortical carcinoma progression. Oncotarget 7, 3233–3244.10.18632/oncotarget.6564Search in Google Scholar PubMed PubMed Central

Yang, X., Zhao, M., Xia, M., Liu, Y., Yan, J., Ji, H., and Wang, G. (2012). Selective requirement for Mediator MED23 in Ras-active lung cancer. Proc. Natl. Acad. Sci. USA 109, E2813–E2822.10.1073/pnas.1204311109Search in Google Scholar PubMed PubMed Central

Yang, Q., Diamond, M.P., and Al-Hendy, A. (2016). Early life adverse environmental exposures increase the risk of uterine fibroid development: role of epigenetic regulation. Front Pharmacol. 7, 40.10.3389/fphar.2016.00040Search in Google Scholar PubMed PubMed Central

Yin, J.W. and Wang, G. (2014). The mediator complex: a master coordinator of transcription and cell lineage development. Development 141, 977–987.10.1242/dev.098392Search in Google Scholar PubMed

Yun, J., Son, C.H., Um, S.J., Kwon, H.C., Lee, K.E., Choi, P.J., and Roh, M.S. (2011). A different TRAP220 expression in distinct histologic subtypes of lung adenocarcinoma and the prognostic significance. Lung Cancer 71, 312–318.10.1016/j.lungcan.2010.06.012Search in Google Scholar PubMed

Yun, S.I., Kim, H.H., Yoon, J.H., Park, W.S., Hahn, M.J., Kim, H.C., Chung, C.H., and Kim, K.K. (2015). Ubiquitin specific protease 4 positively regulates the WNT/beta-catenin signaling in colorectal cancer. Mol. Oncol. 9, 1834–1851.10.1016/j.molonc.2015.06.006Search in Google Scholar PubMed PubMed Central

Zhu, Y., Wang, M., Zhao, X., Zhang, L., Wu, Y., Wang, B., and Hu, W. (2017). Rottlerin as a novel chemotherapy agent for adrenocortical carcinoma. Oncotarget 8, 22825–22834.10.18632/oncotarget.15221Search in Google Scholar PubMed PubMed Central